A Leishmania amastigote-specific hypothetical protein evaluated as recombinant protein plus Th1 adjuvant or DNA plasmid-based vaccine to protect against visceral leishmaniasis.
Oliveira-da-Silva JA, Machado AS, Ramos FF, Tavares GSV, Lage DP, Mendonça DVC, Pereira IAG, Santos TTO, Martins VT, Carvalho LM, Freitas CS, Ludolf F, Reis TAR, Bandeira RS, Silva AM, Costa LE, Oliveira JS, Duarte MC, Roatt BM, Teixeira AL, Coelho EAF.
Oliveira-da-Silva JA, et al. Among authors: duarte mc.
Cell Immunol. 2020 Oct;356:104194. doi: 10.1016/j.cellimm.2020.104194. Epub 2020 Aug 13.
Cell Immunol. 2020.
PMID: 32827943